Chiamaka L Okorie

Ms. Chiamaka L Okorie

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 September 2023 in Experimental Dermatology
Verified
Journal Article
Closed access
COChiamaka L Okorie
Chiamaka L Okorie
KNKrithika Nayudu
Krithika Nayudu
VNVinod E. Nambudiri
Vinod E. Nambudiri

13 May 2022 in PLOS ONE
Verified
Journal Article
Open access
PDF file
COChiamaka L Okorie
Chiamaka L Okorie
EGElise Gatsby
Elise Gatsby
FSFlorian R. Schroeck
Florian R. Schroeck
AIAbdol Aziz Ould Ismail
Abdol Aziz Ould Ismail
KLKristine E. Lynch
Kristine E. Lynch
Background: Healthcare providers are often targeted as research participants, especially for implementation science studies evaluating provider- or system-level issues. Frequently, provider eligibility is based on both provider and patient factors. Manual chart review and self-report are common provider screening strategies but require substantial time, effort, and resources. The automated use of electronic health record (EHR) data may streamline provider identification for implementation science research. Here, we describe an approach to provider screening for a Veterans Health Administration (VHA)-funded study focused on implementing risk-aligned surveillance for bladder cancer patients. Methods: Our goal was to identify providers at 6 pre-specified facilities who performed ≥10 surveillance cystoscopy procedures among bladder cancer patients in the 12 months prior to recruitment start on January 16, 2020, and who were currently practicing at 1 of 6 pre-specified facilities. Using VHA EHR data (using CPT, ICD10 procedure, and ICD10 diagnosis codes), we identified cystoscopy procedures performed after an initial bladder cancer diagnosis (i.e., surveillance procedures). Procedures were linked to VHA staff data to determine the provider of record, the number of cystoscopies they performed, and their current location of practice. To validate this approach, we performed a chart review of 105 procedures performed by a random sample of identified providers. The proportion of correctly identified procedures was calculated (Positive Predictive Value (PPV)), along with binomial 95% confidence intervals (CI). Findings: We identified 1,917,856 cystoscopies performed on 703,324 patients from October 1, 1999—January 16, 2020, across the nationwide VHA. Of those procedures, 40% were done on patients who had a prior record of bladder cancer and were completed by 15,065 distinct providers. Of those, 61 performed ≥ 10 procedures and were currently practicing at 1 of the 6 facilities of interest in the 1 year prior to study recruitment. The random chart review of 7 providers found 101 of 105 procedures (PPV: 96%; 95% CI: 91% to 99%) were surveillance procedures and were performed by the selected provider on the recorded date. Implications: These results show that EHR data can be used for accurate identification of healthcare providers as research participants when inclusion criteria consist of both patient- (temporal relationship between diagnosis and procedure) and provider-level (frequency of procedure and location of current practice) factors. As administrative codes and provider identifiers are collected in most, if not all, EHRs for billing purposes this approach can be translated from provider recruitment in VHA to other healthcare systems. Implementation studies should consider this method of screening providers.

14 April 2023 in Journal of Cutaneous Pathology
Verified
Journal Article
Closed access
COChiamaka L Okorie
Chiamaka L Okorie
SYShaofeng Yan
Shaofeng Yan
DKDarcy A. Kerr
Darcy A. Kerr
LTLaura J. Tafe
Laura J. Tafe
ASAravindhan Sriharan
Aravindhan Sriharan

4 November 2023 in Clinical and Experimental Dermatology
Verified
Journal Article
Closed access
JKJamie L Karch
Jamie L Karch
COChiamaka L Okorie
Chiamaka L Okorie
MMMayra B C Maymone
Mayra B C Maymone
MLMelissa Laughter
Melissa Laughter
NVNeelam A Vashi
Neelam A Vashi
Background: COVID-19, the widely recognized and highly contagious respiratory tract infection, has had a substantial impact on the field of dermatology since its emergence in 2019. SARS-CoV-2, the causative virus of COVID-19, is classified as an RNA virus. Various skin-related symptoms have been reported in patients with COVID-19, most notably the distinctive purple–red acral rash resembling chilblain lesions, commonly referred to as ‘COVID toe’; similarly, skin-related symptoms have been observed in connection with other RNA viruses. Objectives: To explore the relationship between RNA viruses and their associated vascular cutaneous manifestations vs. those observed in patients infected with SARS-CoV-2. Methods: A systematic literature review was conducted using PubMed and medical subject heading terms related to RNA viruses and related skin manifestations. Results: In total, 3994 patients diagnosed with COVID-19 presenting with skin rashes were included. Chilblain-like lesions were most frequently observed (30.2%), followed by erythematous maculopapular/morbilliform rashes (9.1%) and urticarial rashes (4.7%). Of 8362 patients diagnosed with RNA viruses, more than half of the skin findings reported were erythematous/maculopapular/morbilliform rashes (52.3%), followed by unspecified (11.3%) and purpuric rashes (10.6%). Conclusions: When comparing RNA viral infections with COVID-19 infection, we observed similarities in the reported skin manifestations and their presumed pathways, with many implicated in the proinflammatory response. Owing to the wide range of cutaneous symptoms associated with RNA viruses and our currently limited understanding of the underlying mechanisms, additional research is warranted to investigate the pathology behind viral-induced skin lesions.

31 July 2023 in JAAD Case Reports
Verified
Journal Article
Open access
DEDjoni Elkady
Djoni Elkady
COChiamaka L Okorie
Chiamaka L Okorie
BEBlanca Estupiñan
Blanca Estupiñan
MMMitul B. Modi
Mitul B. Modi
SCScott J. Cotler
Scott J. Cotler
ELEden Lake
Eden Lake

24 July 2023 in Archives of Dermatological Research
Verified
Journal Article
Closed access
PDF file
COChiamaka L Okorie
Chiamaka L Okorie
DEDjoni Elkady
Djoni Elkady
VNVinod E. Nambudiri
Vinod E. Nambudiri